Dr. Torchia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dana-Farber Cancer Institute
Boston, MA 02127
Education & Training
Stanford University School of MedicineClass of 2015
Certifications & Licensure
MA State Medical License 2015 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 93 citationsEmerging concepts in PD-1 checkpoint biology.Kristen E. Pauken, James A. Torchia, Apoorvi Chaudhri, Arlene H. Sharpe, Gordon J. Freeman
Seminars in Immunology. 2021-05-15 - 124 citationsTREM2, a DAP12-Associated Receptor, Regulates Osteoclast Differentiation and Function†Mary Beth Humphrey, Michael R. Daws, Steven C. Spusta, Eréne C. Niemi, James A. Torchia
Journal of Bone and Mineral Research. 2005-10-20 - 281 citationsDepleting tumor-specific Tregs at a single site eradicates disseminated tumorsAurélien Marabelle, Holbrook E Kohrt, Idit Sagiv-Barfi, Bahareh Ajami, Robert C. Axtell
The Journal of Clinical Investigation. 2013-06-03
Press Mentions
Breakthrough! Receptor “Decoy” Drug Neutralizes COVID-19 Virus Together with Omicron and Different VariantsDecember 26th, 2022- New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its VariantsDecember 7th, 2022
- Experimental Decoy Drug Tricks Coronavirus, Then Destroys ItDecember 7th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
